"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Emcure Pharmaceuticals Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : Berjis M Desai
Home : Indian Private	Book Value: 195.6489724
BSE Code : 544210	Market Cap: 32922.05
NSE Code : EMCURE	P / E : 43.79

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Type	4Qtr	3Qtr	2Qtr	1Qtr
Net Sales	1467.70	1418.31	1260.60	1096.57
Other Income	34.52	138.30	22.75	21.52
Total Income	1502.22	1556.61	1283.36	1118.10
Total Expenditure	1096.05	1146.95	1036.01	872.07
Operating Profit	406.17	409.65	247.34	246.02
Interest	36.87	33.15	27.71	20.54
Gross Profit	369.31	376.50	219.63	225.49
Depreciation	63.04	62.14	61.74	59.82
Tax	78.86	64.89	45.98	44.00
Deferred Tax	-6.29	-9.38	-5.71	-1.12
Reported Profit After Tax	233.70	258.85	117.62	122.79

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView